Representative Matters

Print PDF
Client: Pharmaceuticals
Represented manufacturer of pharmaceuticals, its parent company, and certain members of management in a stock drop class action in which plaintiffs alleged that defendants violated the Securities Exchange Act of 1934 by making misleading disclosures regarding the company’s compliance with certain Food and Drug Administration (FDA) regulations that artificially inflated the company’s stock price.

Practice Areas